Home Data Calendar Blog

FDMT

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Common Stock Value 0.000.000.000.000.000.000.000.000.000.000.000.00NANANA
dei: Entity Common Stock Shares Outstanding NANANANANANANANANANANANANANANA
Weighted Average Number Of Diluted Shares Outstanding 42.2638.3432.72NA32.3932.3232.23NA27.0226.74NANANANANA
Weighted Average Number Of Shares Outstanding Basic 42.2638.3432.72NA32.3932.3232.23NA27.0226.74NANANANANA
Weighted Average Number Of Share Outstanding Basic And Diluted NANANANANANA32.23NA27.0226.7426.69NA5.205.185.18
Earnings Per Share Basic -0.24-0.77-0.88-0.84-0.79-0.87-0.82-0.85-0.82-0.28NANANANANA
Earnings Per Share Diluted -0.24-0.77-0.88-0.84-0.79-0.87-0.82-0.85-0.82-0.28NANANANANA
Earnings Per Share Basic And Diluted NANANANANANA-0.82-0.85-0.82-0.28-0.61-1.85-1.51-2.92-2.54

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue From Contract With Customer Excluding Assessed Tax 20.200.240.301.250.500.161.220.091.3714.582.00-0.987.423.513.41
Revenues 20.200.240.301.250.500.161.220.091.3714.582.00-0.987.423.633.54
Operating Expenses 34.1832.3830.4029.9727.0028.5927.6124.8624.0322.1818.3119.4515.2418.7816.81
Research And Development Expense Excluding Acquired In Process Cost 25.0723.5822.4121.5018.9420.4219.3817.5315.8415.2212.77NANANANA
General And Administrative Expense 9.118.797.998.478.058.178.237.338.196.955.546.843.683.063.65
Operating Income Loss -13.97-32.14-30.11-28.72-26.50-28.43-26.39-24.76-22.66-7.60-16.31-20.42-7.82-15.15-13.28
Allocated Share Based Compensation Expense 4.564.974.224.354.524.323.933.733.923.822.331.721.151.041.08
Profit Loss -10.26-29.62-28.68-27.38-25.69-28.09-26.34-25.08-22.24-7.59-16.41-20.55-7.83-15.15-13.16
Net Income Loss -10.26-29.62-28.68-27.38-25.69-28.09-26.34-25.08-22.24-7.59-16.41-20.55-7.83-15.15-13.16
Comprehensive Income Net Of Tax -10.07-29.00-27.76-26.72-25.71-28.49-27.34-25.31-22.43-7.59-16.41-20.55-7.83NANA
Net Income Loss Available To Common Stockholders Basic -10.26-29.62-28.68-27.38-25.69-28.09-26.34-25.08-22.24-7.59-16.41-20.55-7.83-15.15-13.16

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Assets 361.61352.50244.02261.85280.16302.94324.93353.49240.62254.93270.11288.33NANANA
Liabilities 31.6827.3625.4130.5128.7230.4228.8734.3816.4814.2927.6831.94NANANA
Liabilities And Stockholders Equity 361.61352.50244.02261.85280.16302.94324.93353.49240.62254.93270.11288.33NANANA
Stockholders Equity 329.93325.14218.61231.34251.44272.52296.06319.11224.13240.65242.43256.39-105.29-99.16-85.04

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Assets Current 328.24317.78207.04220.51232.48246.52243.05256.28165.73248.75264.50282.66NANANA
Cash And Cash Equivalents At Carrying Value 275.68236.3178.5752.35108.30113.4875.97153.0090.99243.74259.87276.73NANANA
Marketable Securities Current 43.9974.03121.89161.20119.42127.60160.1894.78NANANANANANANA
Prepaid Expense And Other Assets Current 8.587.436.596.964.765.436.898.463.273.793.674.44NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Property Plant And Equipment Gross 31.5731.1330.3729.9928.7727.2924.1919.7213.7610.179.238.92NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 10.839.848.767.736.716.205.735.334.974.594.223.84NANANA
Property Plant And Equipment Net 20.7421.3021.6122.2622.0521.1018.4614.398.795.585.015.07NANANA
Other Assets Noncurrent 0.681.081.261.081.050.960.880.600.600.600.600.60NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Liabilities Current 18.1613.7511.2815.7313.5614.3312.0916.3411.379.8713.9216.74NANANA
Accounts Payable Current 4.713.492.413.321.483.322.684.763.711.961.281.79NANANA
Other Accrued Liabilities Current 0.160.050.040.380.190.750.211.770.420.360.300.49NANANA
Accrued Liabilities Current 10.196.585.418.877.246.165.267.74NANANA8.37NANANA
Contract With Customer Liability Current 0.130.580.780.882.212.262.112.601.733.027.096.59NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Other Liabilities Noncurrent 0.020.020.030.020.020.010.010.121.891.871.861.85NANANA
Operating Lease Liability Noncurrent 12.0312.5313.0113.4713.9214.4014.7815.22NANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Stockholders Equity 329.93325.14218.61231.34251.44272.52296.06319.11224.13240.65242.43256.39-105.29-99.16-85.04
Common Stock Value 0.000.000.000.000.000.000.000.000.000.000.000.00NANANA
Additional Paid In Capital Common Stock 712.44697.58562.04547.02540.40535.76530.81526.52406.24400.32394.51392.06NANANA
Retained Earnings Accumulated Deficit -383.04-372.79-343.17-314.49-287.11-261.42-233.33-207.00-181.91-159.67-152.09-135.68NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax 0.530.34-0.27-1.20-1.85-1.83-1.42-0.42-0.20NANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 4.564.974.22NA4.524.323.93NA3.923.822.33NA1.151.041.08

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Operating Activities -1.17-22.07-27.91-22.21-21.02-19.90-23.55-21.84-15.72-16.20-15.37-17.50-13.37-6.17-13.87
Net Cash Provided By Used In Investing Activities 29.9849.2943.13-35.7815.3757.47-54.11-32.29-139.01-0.74-0.64-0.510.35-0.12-0.72
Net Cash Provided By Used In Financing Activities 10.56130.5210.992.050.46-0.050.63116.141.980.82-0.85205.980.9072.49-0.39

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Operating Activities -1.17-22.07-27.91-22.21-21.02-19.90-23.55-21.84-15.72-16.20-15.37-17.50-13.37-6.17-13.87
Net Income Loss -10.26-29.62-28.68-27.38-25.69-28.09-26.34-25.08-22.24-7.59-16.41-20.55-7.83-15.15-13.16
Profit Loss -10.26-29.62-28.68-27.38-25.69-28.09-26.34-25.08-22.24-7.59-16.41-20.55-7.83-15.15-13.16
Increase Decrease In Accounts Receivable NANANA0.000.000.00-0.05-0.74-0.430.25-0.520.590.17-0.15-0.10
Increase Decrease In Accounts Payable 1.370.95-0.331.51-1.700.23-1.681.660.800.43-0.600.57-2.772.58-0.33
Share Based Compensation 4.564.974.224.354.524.323.933.733.923.822.331.721.151.041.08

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Investing Activities 29.9849.2943.13-35.7815.3757.47-54.11-32.29-139.01-0.74-0.64-0.510.35-0.12-0.72
Payments To Acquire Property Plant And Equipment 0.410.811.011.091.962.076.415.102.630.740.640.51-0.350.120.72

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Financing Activities 10.56130.5210.992.050.46-0.050.63116.141.980.82-0.85205.980.9072.49-0.39

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenues 20.200.240.301.250.500.161.220.091.3714.582.00-0.987.423.633.54
Astellas, Collaboration And License Revenue 20.01NANANANANANANANANANANANANANA
Cystic Fibrosis Foundation, Collaboration And License Revenue 0.150.010.000.000.000.000.030.090.010.020.000.06-0.05-0.060.02
Uni Qure Biopharma B V, Collaboration And License Revenue 0.040.230.291.250.500.161.190.010.060.270.390.240.260.120.12
F Hoffmann La Roche Ltd And Hoffmann La Roche Inc, Two Thousand And Seventeen Roche Agreement NANANANANANA0.000.001.3014.301.60-1.307.203.603.40
Collaboration And License Revenue 20.200.240.301.250.500.161.220.091.3714.582.00NANA3.633.54
0.040.230.291.250.500.161.190.010.060.270.390.240.260.120.12
US 20.160.010.000.000.000.000.030.090.010.020.000.06-0.05-0.060.02
Revenue From Contract With Customer Excluding Assessed Tax 20.200.240.301.250.500.161.220.091.3714.582.00-0.987.423.513.41

Plots across concepts


IncomeStatement
Operating Income Loss
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Contract With Customer Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:CounterpartyName, us-gaap:ProductOrService
(None, 'fdmt:CollaborationAndLicenseRevenue')
Revenuesus-gaap: Counterparty Name, us-gaap: Product Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByAssetClass, us-gaap:InvestmentType
(None, 'fdmt:LongTermMarketableSecurities')
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Asset Class, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FairValueByAssetClass, us-gaap:InvestmentType
(None, 'fdmt:LongTermMarketableSecurities')
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Fair Value By Asset Class, us-gaap: Investment Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:InvestmentType
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Investment Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:CounterpartyName, us-gaap:ProductOrService
(None, 'fdmt:CollaborationAndLicenseRevenue')
Revenuesus-gaap: Counterparty Name, us-gaap: Product Or Service